Compare with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ALEMBIC PHARMA ALKEM LABORATORIES/
ALEMBIC PHARMA
 
P/E (TTM) x 21.0 28.9 72.6% View Chart
P/BV x 4.8 2.9 164.6% View Chart
Dividend Yield % 1.0 1.8 55.1%  

Financials

 ALKEM LABORATORIES   ALEMBIC PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-21
ALEMBIC PHARMA
Mar-21
ALKEM LABORATORIES/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs3,1501,150 273.9%   
Low Rs2,224527 421.9%   
Sales per share (Unadj.) Rs741.4274.4 270.2%  
Earnings per share (Unadj.) Rs135.356.7 238.6%  
Cash flow per share (Unadj.) Rs158.366.0 239.6%  
Dividends per share (Unadj.) Rs30.0014.00 214.3%  
Avg Dividend yield %1.11.7 66.9%  
Book value per share (Unadj.) Rs616.8260.9 236.5%  
Shares outstanding (eoy) m119.57196.56 60.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.63.1 118.6%   
Avg P/E ratio x19.914.8 134.3%  
P/CF ratio (eoy) x17.012.7 133.7%  
Price / Book Value ratio x4.43.2 135.5%  
Dividend payout %22.224.7 89.8%   
Avg Mkt Cap Rs m321,244164,818 194.9%   
No. of employees `000NANA-   
Total wages/salary Rs m16,21010,512 154.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m88,65053,931 164.4%  
Other income Rs m2,332875 266.6%   
Total revenues Rs m90,98254,806 166.0%   
Gross profit Rs m19,42414,801 131.2%  
Depreciation Rs m2,7461,835 149.7%   
Interest Rs m589160 367.8%   
Profit before tax Rs m18,42113,681 134.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2432,533 88.6%   
Profit after tax Rs m16,17811,148 145.1%  
Gross profit margin %21.927.4 79.8%  
Effective tax rate %12.218.5 65.8%   
Net profit margin %18.220.7 88.3%  
BALANCE SHEET DATA
Current assets Rs m69,28825,779 268.8%   
Current liabilities Rs m36,04112,808 281.4%   
Net working cap to sales %37.524.1 155.9%  
Current ratio x1.92.0 95.5%  
Inventory Days Days2023 83.3%  
Debtors Days Days662 2,805.0%  
Net fixed assets Rs m34,82541,311 84.3%   
Share capital Rs m239393 60.8%   
"Free" reserves Rs m73,51750,883 144.5%   
Net worth Rs m73,75651,276 143.8%   
Long term debt Rs m3431,999 17.1%   
Total assets Rs m104,11467,090 155.2%  
Interest coverage x32.386.4 37.3%   
Debt to equity ratio x00 11.9%  
Sales to assets ratio x0.90.8 105.9%   
Return on assets %16.116.9 95.5%  
Return on equity %21.921.7 100.9%  
Return on capital %25.726.0 98.7%  
Exports to sales %22.166.8 33.0%   
Imports to sales %012.7 0.0%   
Exports (fob) Rs m19,55536,020 54.3%   
Imports (cif) Rs mNA6,845 0.0%   
Fx inflow Rs m19,55536,020 54.3%   
Fx outflow Rs m2,4676,845 36.0%   
Net fx Rs m17,08829,175 58.6%   
CASH FLOW
From Operations Rs m12,64914,634 86.4%  
From Investments Rs m-9,985-8,388 119.0%  
From Financial Activity Rs m-2,718-5,974 45.5%  
Net Cashflow Rs m-17262 -6.6%  

Share Holding

Indian Promoters % 57.1 69.1 82.7%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 19.6 17.8 110.1%  
FIIs % 5.4 6.0 89.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 30.4 141.1%  
Shareholders   81,869 106,437 76.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Ends 236 Points Lower, Nifty Falls Below 16,150; IT & FMCG Stocks Witness Selling(Closing)

Indian share markets ended on a negative note today as global cues remained weak.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


May 24, 2022 03:31 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS